Work

A phase I clinical trial of MVA expressing 5T4 and high-dose interleukin-2 (IL-2) for metastatic renal cell carcinoma

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.12500

Authors: H. L. Kaufman, G. Deraffele, J. Mitcham, D. Moroziewicz, S. Kim-Schulze, C. A. Petrulio, R. Harrop, S. Naylor

Institution: Columbia University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599828246

Cites:

Cited by: 5

Related to: 10